Muhammad Saghir Khan

ORCID: 0000-0003-4213-275X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Advances in Oncology and Radiotherapy
  • Family Support in Illness
  • Legume Nitrogen Fixing Symbiosis
  • Lymphoma Diagnosis and Treatment
  • Palliative Care and End-of-Life Issues
  • Agronomic Practices and Intercropping Systems
  • COVID-19 and healthcare impacts
  • Ethics and Legal Issues in Pediatric Healthcare
  • Adolescent and Pediatric Healthcare
  • Plant Stress Responses and Tolerance
  • Global Health Workforce Issues
  • Neuroblastoma Research and Treatments
  • Burn Injury Management and Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Agricultural Science and Fertilization
  • Herbal Medicine Research Studies
  • Renal cell carcinoma treatment
  • Global Cancer Incidence and Screening
  • Neonatal Respiratory Health Research
  • Plant-Microbe Interactions and Immunity
  • CNS Lymphoma Diagnosis and Treatment
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Chromium effects and bioremediation

King Faisal Specialist Hospital & Research Centre
2021-2025

Tawam Hospital
2020-2021

Shaukat Khanum Memorial Cancer Hospital and Research Center
2015-2020

Aligarh Muslim University
2011-2019

Loyola University Medical Center
2003

Loyola University Chicago
2003

Abstract The COVID‐19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment children with cancer we have witnessed in last few decades. This Special Report aims summarize general principles for continuing multidisciplinary care during SARS‐CoV‐2 (COVID‐19) pandemic. With contributions from leadership International Society Pediatric Oncology (SIOP), Children's Group (COG), St Jude Global program, Childhood Cancer International, sought provide a...

10.1002/pbc.28409 article EN Pediatric Blood & Cancer 2020-05-13

Introduction Initiated in June 2019, this collaborative effort involved 15 public and private sector hospitals Pakistan. The primary objective was to enhance the capacity for pediatric neuro-oncology (PNO) care, supported by a My Child Matters/Foundation S grant. Methods We aimed establish operate Multidisciplinary Tumor Boards (MTBs) on national scale, covering 76% of population (185.7 million people). In response COVID-19 pandemic, MTBs transitioned videoconferencing. Fifteen with...

10.3389/fonc.2024.1325167 article EN cc-by Frontiers in Oncology 2024-02-29

ABSTRACT A long pre‐diagnostic interval is reported to be a significant challenge in childhood cancer, particularly low‐ and middle‐income countries (LMICs) where advanced‐stage disease at diagnosis results poor survival. The International Society of Paediatric Oncology the Pediatric Association launched “Childhood Cancer Early Diagnosis Appropriate Referral (CEDAR)” project 2022 as educational webinars on six index cancers World Health Organization Global Initiative for Childhood improve...

10.1002/pbc.31702 article EN Pediatric Blood & Cancer 2025-04-08

In Asia, a few countries have long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not such groups. The process forming groups is fraught with hurdles, which varies among the countries. One basic requirements for running an affordable health care system in most children can receive proposed treatment. insurance coverage from <20% to as high 100% Asian countries, operation must also be adjusted...

10.1200/go.23.00153 article EN JCO Global Oncology 2023-09-01

Abstract Purpose In the absence of a standardized tool to assess quality pediatric hematology/oncology training programs, Education Program Assessment Tool (EPAT) was conceptualized as user‐friendly and adaptable evaluate identify areas opportunity, pinpoint needed modifications, monitor progress for programs around world. Methods The development EPAT consisted three main phases: operationalization, consensus, piloting. After each phase, iteratively modified based on feedback improve its...

10.1002/cncr.34946 article EN Cancer 2023-07-07

Abstract The COVID‐19 pandemic quickly led to an abundance of publications and recommendations, despite a paucity information on how affects children with cancer. This created dire need for trusted resource curated space the pediatric oncology community share experiences. Global Observatory Resource Center Childhood Cancer was developed, launched, maintained by International Society Pediatric Oncology St. Jude Children's Research Hospital. three components (Resource Library, Registry,...

10.1002/pbc.28962 article EN Pediatric Blood & Cancer 2021-02-24

Access to essential cancer medicines is a major determinant of childhood outcomes globally. The degree which pediatric oncologists deem listed on WHO's Model List Essential Medicines for Children (EMLc) unknown, as the extent such are accessible front lines clinical care.An electronic survey developed was distributed through International Society Pediatric Oncology mailing list members from 87 countries. Respondents were asked select 10 that would provide greatest benefit patients in their...

10.1200/go.22.00034 article EN JCO Global Oncology 2022-06-01

Abstract Background Tumor boards are part of standard care patients with complex cancers, but appropriate multidisciplinary expertise and infrastructure often not available in low‐ middle‐income countries (LMIC) for pediatric such as neuroblastoma. Our goal was to review results a Global Neuroblastoma Network (GNN) tumor board accessible LMIC. Methods De‐identified clinical cases presented via internet conference during weekly GNN virtual from 2010 through 2020 were evaluated standardized...

10.1002/pbc.29568 article EN Pediatric Blood & Cancer 2022-01-27

Inadequate numbers of trained health care providers (HCPs) contribute to poor pediatric oncology (PO) outcomes, particularly in low- and lower middle-income countries (L/LMICs). An understanding the characteristics workforce challenges is vital for addressing these problems.The Pediatric Oncology East Mediterranean (POEM) Group surveyed PO centers North Africa, Middle East, Central Asia, Indian subcontinent on infrastructure capacity, service availability, training opportunities HCPs....

10.1002/pbc.29190 article EN Pediatric Blood & Cancer 2021-07-01

The objectives of this study were to evaluate the prognostic impact pre-referral surgical resection Wilms tumor (WT) performed at non-oncology centers, and strategize an improved care plan for very curable pediatric tumor.In conducted in a large cancer center Pakistan, we retrospectively reviewed electronic medical records (EMR) 149 patients with unilateral WT from September 2008 August 2017. Based on treatment approach, categorized into two groups: (i) (PTR: n = 75), (ii) post-neoadjuvant...

10.1002/pbc.30760 article EN Pediatric Blood & Cancer 2023-11-14

While pediatric cancer survival rates have improved in high-income countries, they remain much lower low- and middle-income countries (L/MICs). focus recent years has been on remediating the survivorship gap, less is known about psychosocial needs availability of services for this population.A questionnaire was created by SIOP Global Health Network Psychosocial Working Group to assess L/MIC. The distributed oncology professionals, both in-person at Annual Congress Lyon (2019) conference then...

10.1002/pon.6222 article EN Psycho-Oncology 2023-10-05

Long-term survivors of childhood malignancies are at increased risk experiencing treatment-related morbidities. Survival into late adulthood in these children provides ample time for the acquisition long-term sequelae. This study aimed to determine adverse effects among cancer from a low-income country perspective.Data were retrospectively collected review charts patients aged under 18 years their primary diagnosis between 1 January, 1995, and 31 December, 2008, who survived least 5 after...

10.37029/jcas.v6i2.351 article EN cc-by-nc-sa Journal of Cancer & Allied Specialties 2020-05-12

Objectives: 1:To determine outcome of first relapse Hodgkin Lymphoma with standard dose chemotherapy. 2: To identify the prognostic factors predicting survival in pediatric relapsed lymphoma. Methods: This was a retrospective analysis 43 patients HL who at least 3 months after completion initial treatment from January 2001 to December 2010. Probabilities OS, EFS and cumulative incidence were calculated by Kaplan-Meier method. Log rank tests used compare curves p-value&lt;0.05 considered...

10.47391/jpma.1114 article EN cc-by Journal of the Pakistan Medical Association 2020-11-20

Background : Inadequate numbers of trained healthcare providers (HCPs), contribute to poor pediatric oncology (PO) outcomes, particularly in low- and lower middle–income countries (L/LMICs). An understanding the characteristics workforce challenges are vital for addressing these problems. Methods The Pediatric Oncology East Mediterranean (POEM) Group surveyed PO centers North Africa, Middle East, Central Asia Indian subcontinent on infrastructure capacity, service availability, training...

10.1002/pbc.29858 article EN Pediatric Blood & Cancer 2022-06-17

Khan, M.; Shamim, Fazal, N.; Hu, Z.; Goyal, A.; Raziudin, S.; Sayeed, M. Author Information

10.1097/00024382-200306001-00241 article EN Shock 2003-06-01

To review the outcomes of refractory and relapsed Hodgkin's Lymphoma in pediatric patients treated with high dose chemotherapy (HDC) followed by autologous stem cell transplantation (ASCT) at a single center. All patients, up to age 18 years, or who had complete good-partial response salvage were included study. received HDC ASCT during October 2010 June 2014. Medical records these reviewed. The following variables collected addition demographics stage disease time relapse. Time engraftment...

10.1016/j.bbmt.2014.11.172 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2015-01-22
Coming Soon ...